| scholarly article | Q13442814 |
| P50 | author | Dominik J. Schaer | Q73276503 |
| Monique P Gelderman | Q98228317 | ||
| P2093 | author name string | Jin Hyen Baek | |
| Paul W Buehler | |||
| Florence Vallelian | |||
| Michele Puglia | |||
| Ayla Yalamanoglu | |||
| Bo Burla | |||
| Jaroslav Vostal | |||
| P2860 | cites work | Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases | Q44496573 |
| L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy | Q44560867 | ||
| Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model | Q44810013 | ||
| Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. | Q45927690 | ||
| Transferrin therapy ameliorates disease in beta-thalassemic mice. | Q50586962 | ||
| Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. | Q51071336 | ||
| Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. | Q52576436 | ||
| High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin | Q56490134 | ||
| Mechanisms of Renal Disease in -Thalassemia | Q57998237 | ||
| Glomerular protein sieving and implications for renal failure in Fanconi syndrome | Q60021528 | ||
| Survival and causes of death in thalassaemia major | Q69371167 | ||
| A family of congenital atransferrinemia | Q69375323 | ||
| Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes | Q72009930 | ||
| Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis | Q73351337 | ||
| [Haptoglobin determination in serum, normal concentrations and relation to Smithies' serum groups] | Q77063852 | ||
| Competitive advantage of diferric transferrin in delivering iron to reticulocytes | Q24602162 | ||
| Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice | Q24633423 | ||
| Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity | Q28200990 | ||
| Identification of erythroferrone as an erythroid regulator of iron metabolism | Q28240988 | ||
| Beta-thalassemia | Q28272228 | ||
| Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells | Q28509880 | ||
| A mouse model for beta 0-thalassemia | Q28587408 | ||
| Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells | Q33895206 | ||
| Molecular liaisons between erythropoiesis and iron metabolism | Q33948684 | ||
| Transferrin: evolution and genetic regulation of expression | Q34164485 | ||
| Erythroferrone contributes to recovery from anemia of inflammation | Q34353734 | ||
| Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression | Q34658174 | ||
| The mouse age phenome knowledgebase and disease-specific inter-species age mapping | Q35061186 | ||
| The second transferrin receptor regulates red blood cell production in mice | Q35446281 | ||
| β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism | Q35485724 | ||
| Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload | Q35578602 | ||
| Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. | Q35858087 | ||
| An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis | Q35865381 | ||
| Iron overload and chelation | Q36270045 | ||
| Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy | Q36444526 | ||
| Normal structure, function, and histology of the spleen | Q36635909 | ||
| Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia | Q36787514 | ||
| Non-transfusion-dependent thalassemias | Q36892558 | ||
| Hepcidin and disorders of iron metabolism | Q37795819 | ||
| Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter | Q39736112 | ||
| Lack of haptoglobin affects iron transport across duodenum by modulating ferroportin expression. | Q40071451 | ||
| Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin | Q40868522 | ||
| Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity | Q42024944 | ||
| Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. | Q42913158 | ||
| Automated assay for non-transferrin-bound iron in serum samples | Q42939592 | ||
| A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer | Q44248053 | ||
| Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. | Q44365006 | ||
| P433 | issue | 5 | |
| P921 | main subject | heterozygosity | Q124059385 |
| P304 | page(s) | 611-622 | |
| P577 | publication date | 2015-01-23 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice | |
| P478 | volume | 100 |
| Q61451281 | A computational model to understand mouse iron physiology and disease |
| Q92482678 | An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease |
| Q38686059 | Cardiac complications in beta-thalassemia: From mice to men. |
| Q38984609 | Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice |
| Q34489655 | Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia |
| Q28554997 | Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model |
| Q64113730 | Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells |
| Q58580509 | Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess |
| Q47382712 | HRI coordinates translation by eIF2αP and mTORC1 to mitigate ineffective erythropoiesis in mice during iron deficiency |
| Q90286639 | Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies |
| Q39733152 | Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation |
| Q42573907 | Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis |
| Q49837145 | Ineffective Erythropoiesis: Anemia and Iron Overload |
| Q38613789 | Ineffective erythropoiesis and regulation of iron status in iron loading anaemias |
| Q90699380 | Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood |
| Q92710735 | Iron metabolism and iron disorders revisited in the hepcidin era |
| Q55230811 | Management of cardiac hemochromatosis. |
| Q38631586 | Optimizing the diagnosis and the treatment of iron overload diseases |
| Q90288843 | The multifaceted role of iron in renal health and disease |
| Q47885433 | What can we learn from ineffective erythropoiesis in thalassemia? |
Search more.